Law Times - Patrick Kierans
In the media | October 2, 2017
Rejection of doctrine may encourage exaggerated claims
Patrick Kierans, who acted for intervenors Innovative Medicines Canada and BIOTECanada, comments on the AstraZeneca Canada Inc. v. Apotex Inc. Supreme Court of Canada decision and says we’re happy that the promise doctrine is gone.